Cambridge Healthtech Institute's Fifth Annual

Single-Use Technologies and Continuous Processing

( 单次使用技术与连续处理 )

Advancing Bioprocessing through Technological Innovation

2018年1月8日 - 9日

 

The steady adoption of single-use technologies and subsequent move toward continuous processing (CP) for clinical and commercial manufacture has created a great need to evaluate the risks, challenges, opportunities and strategies for implementing these types of technologies into modern day bioprocessing.

Cambridge Healthtech Institute's Fifth Annual Single-Use Technologies and Continuous Processing conference will once again gather technology and equipment providers, end users, and regulators to discuss innovative approaches to current challenges, update companies on the trends in technology, share case studies on successful implementation, and ultimately identify how to derive as much value as possible from these technological advances.

Preliminary Agenda


TECHNOLOGICAL ADVANTAGES IN SINGLE-USE TECHNOLOGIES AND ENABLING CONTINUOUS BIOMANUFACTURING

Technology Advances in Single-Use Technologies

Adam Goldstein, MSc, Principal Scientist, Global Technology, Roche/Genentech

Novel Lipid Supplement Increases mAb Production in Single-Use Bioreactors

Adam Elhofy, Ph.D., CSO, Essential Pharmaceuticals


STANDARDIZATION AND REGULATORY CHALLENGES FOR SINGLE-USE TECHNOLOGIES AND SYSTEMS

BPOG and BPSA Update

Zhaoli Zhou, Ph.D., Manager and Senior Engineer, Process Technology Group, Manufacturing Technology, Sanofi Pasteur


EXTRACTABLES AND LEACHABLES

Characterization of Extractables and Leachables from Disposable Bioreactors

Jonathan Bones, Ph.D., Principal Investigator, National Institute for Bioprocessing Research and Training


CASE STUDIES OF CONTINUOUS PROCESSING IMPLEMENTATION

A Single-Use Strategy to Enable Manufacturing of Affordable Biologics

Renaud Jacquemart, Ph.D., BioPharma Downstream Process Specialist, Natrix Separations


* 活动内容有可能不事先告知作更动及调整。